Cleared Traditional

K202492 - EZ-IO Intraosseous Vascular Access System

K202492 is the FDA 510(k) clearance for EZ-IO Intraosseous Vascular Access System by Teleflex Medical. It is a Class 2 General Hospital device (product code FMI) cleared through the Traditional 510(k) pathway after a 203-day FDA review.

K202492 · Teleflex Medical · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2021
Decision
203d
Days
Class 2
Risk

K202492 is an FDA 510(k) clearance for the EZ-IO Intraosseous Vascular Access System. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Teleflex Medical (Morrisville, US). The FDA issued a Cleared decision on March 22, 2021 after a review of 203 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Teleflex Medical devices

Submission Details

510(k) Number K202492 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 2020
Decision Date March 22, 2021
Days to Decision 203 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d slower than avg
Panel avg: 129d · This submission: 203d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 235
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K202492.
Safety Winged Blood Collection Sets
K211293 · Promisemed Hangzhou Meditech Co., Ltd. · Jun 2021
NovoFine
K210258 · Novo Nordisk, Inc. · Jun 2021
Verifine Safety Type Insulin Pen Needle
K210065 · Promisemed Hangzhou Meditech Co., Ltd. · Apr 2021
Easydrip Pen Needle, Easydrip Plus Pen Needle
K193422 · Sandstone Medical (Suzhou), Inc. · Feb 2021
Promisemed Covered Safety Pen Needle
K202681 · Promisemed Hangzhou Meditech Co., Ltd. · Dec 2020
NovoFine Plus 32G Tip x 4 mm
K202005 · Novo Nordisk, Inc. · Dec 2020